More indirect evidence of potential neuroprotective benefits of angiotensin receptor blockers

被引：13

作者：

Anderson, Craig ^{[1
,2
]}

机构：

[1] Royal Prince Alfred Hosp, Neurol & Mental Hlth Div, George Inst Int Hlth, Sydney, NSW 2050, Australia

[2] Univ Sydney, Neurol & Mental Hlth Div, George Inst Int Hlth, Sydney, NSW 2006, Australia

来源：

JOURNAL OF HYPERTENSION | 2010年 / 28卷 / 03期

关键词：

STROKE;

D O I：

10.1097/HJH.0b013e3283371355

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：429 / 429

页数：1

共 8 条

[1] Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction [J].

Fuentes, Blanca ;

Fernandez-Dominguez, Jessica ;

Angeles Ortega-Casarrubios, M. ;

SanJose, Belen ;

Martinez-Sanchez, Patricia ;

Diez-Tejedor, Exuperio .

JOURNAL OF HYPERTENSION, 2010, 28 (03) :575-581

[2] Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density [J].

Li, Jian-Mei ;

Mogi, Masaki ;

Iwanami, Jun ;

Min, Li-Juan ;

Tsukuda, Kana ;

Sakata, Akiko ;

Fujita, Teppei ;

Iwai, Masaru ;

Horiuchi, Masatsugu .

STROKE, 2008, 39 (07) :2029-2036

[3] Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke [J].

McCarthy, Claudia A. ;

Vinh, Antony ;

Callaway, Jennifer K. ;

Widdop, Robert E. .

STROKE, 2009, 40 (04) :1482-1489

[4]

Thöne-Reineke C, 2006, J HYPERTENS, V24, pS115

[5] Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: meta-analysis of randomised trials [J].

Turnbull, F. ;

Neal, B. ;

Ninomiya, T. ;

Algerl, C. ;

Arima, H. ;

Barzi, F. ;

Bulpitt, C. ;

Chalmers, J. ;

Fagard, R. ;

Gleason, A. ;

Heritier, S. ;

Li, N. ;

Perkovic, V. ;

Woodward, M. ;

MacMahon, S. .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7653) :1121-1123

[6] Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial [J].

Yusuf, S. ;

Teo, K. ;

Anderson, C. ;

Pogue, J. ;

Dyal, L. ;

Copland, I. ;

Schumacher, H. ;

Dagenais, G. ;

Sleight, P. .

LANCET, 2008, 372 (9644) :1174-1183

[7] Telmisartan to prevent recurrent stroke and cardiovascular events [J].

Yusuf, Salim ;

Diener, Hans-Christoph ;

Sacco, Ralph L. ;

Cotton, Daniel ;

Ounpuu, Stephanie ;

Lawton, William A. ;

Palesch, Yuko ;

Martin, Renee H. ;

Albers, Gregory W. ;

Bath, Philip ;

Bornstein, Natan ;

Chan, Bernard P. L. ;

Chen, Sien-Tsong ;

Cunha, Luis ;

Dahlof, Bjorn ;

De Keyser, Jacques ;

Donnan, Geoffrey A. ;

Estol, Conrado ;

Gorelick, Philip ;

Gu, Vivian ;

Hermansson, Karin ;

Hilbrich, Lutz ;

Kaste, Markku ;

Lu, Chuanzhen ;

Machnig, Thomas ;

Pais, Prem ;

Roberts, Robin ;

Skvortsova, Veronika ;

Teal, Philip ;

Toni, Danilo ;

VanderMaelen, Cam ;

Voigt, Thor ;

Weber, Michael ;

Yoon, Byung-Woo .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (12) :1225-1237

[8] Telmisartan, ramipril, or both in patients at high risk for vascular events [J].

Yusuf, Salim ;

Teo, Koon K. ;

Pogue, Janice ;

Dyal, Leanne ;

Copland, Ingrid ;

Schumacher, Helmut ;

Ingelheim, Boehringer ;

Dagenais, Gilles ;

Sleight, Peter ;

Anderson, Craig .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15) :1547-1559

← 1 →